Overall our data suggest that depleting FAP+ tumor stromal cells can decrease the metabolic stress of MAA-specific CD8+ TILs, which delay their differentiation towards functional exhaustion within the TME and result in significantly improved antitumor efficacy. The gene discussed is CD8A; the disease is neoplasm.